Pfizer (NYSE:PFE) will pay up to $250M to settle more than 10,000 U.S. lawsuits alleging that the company concealed cancer ...
Pfizer has agreed to settle more than 10,000 lawsuits which alleged that the company failed to warn patients about possible cancer risks caused by the anti-heartburn medication Zantac. The ...
Pfizer has agreed to pay up to $250mn to settle more than 10,000 US lawsuits over cancer risks associated with its now-discontinued heartburn drug Zantac, according to people familiar with the deal.
opens new tab has agreed to settle more than 10,000 lawsuits ... to Zantac claims, the report said, adding that financial details of the deals were not immediately available. Pfizer did not ...
Pfizer Inc. has agreed to settle more than ... GSK has settled some Zantac cases before they could go to trial. News of the Pfizer settlement surfaced in a filing in state court in Delaware ...
Pfizer (NYSE:PFE) has reportedly agreed to pay up to $250M to settle ... which sold Zantac between 1998 and 2006, said it continues to “vigorously defend against Zantac lawsuits, which it ...
Pfizer has agreed to settle more than 10,000 lawsuits about cancer risks related to the now discontinued heartburn drug Zantac, Bloomberg News reported on Wednesday, citing people familiar with ...
Pfizer has agreed to settle more than ... GSK has also settled some Zantac cases before they could go to trial. News of the Pfizer settlement surfaced in a filing in state court in Delaware ...
Pfizer has agreed to settle more than 10,000 lawsuits alleging it it of hiding the cancer risks of its heartburn drug Zantac. The financial details have not been revealed but pharma rival Sanofi ...
Pfizer Inc. has agreed to settle more than ... GSK has settled some Zantac cases before they could go to trial. News of the Pfizer settlement surfaced in a filing in state court in Delaware ...
Despite this significant resolution, the settlement does not completely absolve Pfizer from its Zantac-related legal challenges. Concerns surrounding potential liabilities stemming from Zantac ...